In the central nervous system, serotonin [5-hydroxytryptamine (5-HT)] is implicated in a wide range of physiological and behavioral functions. The 5-HT neurotransmission is mediated by several serotonergic receptors that are present either on serotonergic neurons or on postsynaptic targets (1). Recent studies indicate that there are at least 14 distinct serotonergic receptors that have been classified into subfamilies based on their structure, sequence similarities, and transduction systems (2, 3). Among them and in agreement with the recent nomenclature of the serotonin club nomenclature Committee (4), the r5-HT 1B and h5-HT 1B receptor subtypes play a key role in controlling the level of 5-HT in the synaptic cleft by regulating its release from rat or human nerve endings, respectively. The r5-HT 1B and h5-HT 1B subtypes function as autoreceptors on serotonergic terminals (5, 6). In addition, these receptor subtypes have been suggested to function as terminal heteroreceptors by regulating the release of the neurotransmitter present in corresponding nerve ending (7-10). Although r5-HT 1B and h5-HT 1B receptors have distinct pharmacological properties, they are distributed with similar patterns with an enrichment in basal ganglia and associated structures in the brain (11).By controlling 5-HT levels in the synaptic cleft, r5-HT 1B and h5-HT 1B receptors may play an important role in neurological disorders where imbalances in serotonin neurotransmission have been reported to occur. Indeed, excessive 5-HT has been associated with anxiety, whereas 5-HT deficits have been observed in depression (12)(13)(14). Stress has been considered as a closely related factor of such disorders. We have previously shown that both auto-and hetero-presynaptic r5-HT 1B receptors were desensitized immediately under stress conditions (15). Moreover, an increase in synthesis, release, and turnover of 5-HT has been observed in the brain of animals subjected to stress (16-19).5-HT-moduline is a cerebral tetrapeptide that was recently isolated and characterized in our laboratory (20,21). We have shown by in vivo and in vitro studies that functional activities of 5-HT 1B receptor subtypes were significantly decreased by this tetrapeptide. 5-HT-moduline may interact with r5-HT 1B and h5-HT 1B receptors at the molecular level by noncompetitive mechanisms and at the functional level by interacting with 5-HT release (20,21). This tetrapeptide may therefore play a fundamental role in various pathological conditions such as depression and anxiety.Knowledge of the distribution of 5-HT-moduline binding sites in rodent brain may represent an essential step in understanding the mechanisms by which 5-HT-moduline behaves under normal physiological conditions. We undertook the present study to determine the distribution of 5-HT-moduline binding sites and to compare it with that of 5-HT 1B receptors. For these purposes, we used both digital autoradiography with a newly developed high resolution -imager, a gaseous detector of  particles (22) as described...